Home/Filings/4/0001193125-25-300644
4//SEC Filing

Ranganath Anil P. 4

Accession 0001193125-25-300644

CIK 0001756262other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:30 PM ET

Size

8.6 KB

Accession

0001193125-25-300644

Insider Transaction Report

Form 4
Period: 2025-11-25
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-25$93.88/sh+3,000$281,64016,955 total
  • Sale

    Common Stock

    2025-11-25$145.22/sh3,000$435,66013,955 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-253,0007,420 total
    Exercise: $93.88Exp: 2033-08-01Common Stock (3,000 underlying)
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Documents

1 file

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001980144

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:30 PM ET
Size
8.6 KB